87 results
Page 3 of 5
8-K
EX-99.2
ky961d02cir pmp
9 Nov 22
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results
7:45am
8-K
EX-99.1
wht1768s
9 Nov 22
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results
7:45am
8-K
EX-99.1
ur7mup
9 Aug 22
Results of Operations and Financial Condition
7:36am
8-K
EX-10.1
e56 3y1otyj5qfp
16 Jun 22
Departure of Directors or Certain Officers
7:45am
8-K
EX-99.1
kfhc ktasmi
12 May 22
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
7:36am
8-K
EX-99.2
3tt6oq41482ju0zv8a
12 May 22
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
7:36am
DEF 14A
2ohi5g87cu
26 Apr 22
Definitive proxy
4:05pm
10-K
EX-10.20
752lnad ykuzli
1 Mar 22
Annual report
4:07pm
10-K
r3w1kycu8
1 Mar 22
Annual report
4:07pm
8-K
EX-99.1
v6c29
1 Mar 22
Xilio Therapeutics Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results
8:00am
8-K
EX-99.1
ci2zjoo
6 Jan 22
Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
7:45am
10-Q
aneazv2caswaqtj
2 Dec 21
Quarterly report
4:15pm
8-K
EX-99.1
gzxx 3lqu9i
2 Dec 21
Xilio Therapeutics Reports Pipeline and Business Progress and Third Quarter 2021 Financial Results
8:00am
424B4
szi0awlazrvc5gtfv7r
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
7nd3vdld3xdj9w9
18 Oct 21
IPO registration (amended)
6:04am
S-1/A
EX-10.5
x4g2pou4h fo
18 Oct 21
IPO registration (amended)
6:04am
S-1/A
EX-10.19
nnrg60yeuvuaa8ctw
18 Oct 21
IPO registration (amended)
6:04am